Our findings are reflective of the complex overlap of metabolic aberrations such as insulin resistance and weight-dependent, altered insulin metabolism associated with obesity and PCOS, which compound the risk of developing GDM. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.